This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …

COVID-19 is a global catastrophic event that causes severe acute respiratory syndrome. The
mechanism of the disease remains unclear, and hypoxia is one of the main complications …

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

Efficacious interventions are urgently needed for the treatment of COVID-19. Here, we report
a monoclonal antibody (mAb), MW05, with SARS-CoV-2 neutralizing activity by disrupting …

The severity of SARS-CoV-2 infection has been related to uncontrolled inflammatory innate
responses and impaired adaptive immune responses mostly due to exhausted T …

The management of sickle cell disease (SCD) and its complications in the COVID-19 era is
very challenging. The recurrent sickling process in SCD causes tissue hypoxemia and micro …

Covid-19 features a delayed onset of critical illness occurring approximately one week from
the beginning of symptoms, which corresponds to the bridging of innate and adaptive …

Dear Editor, The recent coronavirus disease (COVID-19), which was first reported in China,
has spread around the world, causing major public health concerns. 1 Several treatments …